DE69225971D1 - Pen-polymorphismus von menschlichem plättchenmembran-glykoprotein-iiia und diagnostische und therapeutische anwendung davon - Google Patents

Pen-polymorphismus von menschlichem plättchenmembran-glykoprotein-iiia und diagnostische und therapeutische anwendung davon

Info

Publication number
DE69225971D1
DE69225971D1 DE69225971T DE69225971T DE69225971D1 DE 69225971 D1 DE69225971 D1 DE 69225971D1 DE 69225971 T DE69225971 T DE 69225971T DE 69225971 T DE69225971 T DE 69225971T DE 69225971 D1 DE69225971 D1 DE 69225971D1
Authority
DE
Germany
Prior art keywords
diagnostic
glycoprotein
iiia
polymorphism
pen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69225971T
Other languages
English (en)
Inventor
Peter Newman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BLOOD CENTER OF SOUTHEASTERN W
Original Assignee
BLOOD CENTER OF SOUTHEASTERN W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BLOOD CENTER OF SOUTHEASTERN W filed Critical BLOOD CENTER OF SOUTHEASTERN W
Application granted granted Critical
Publication of DE69225971D1 publication Critical patent/DE69225971D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546Integrin superfamily
    • C07K14/70557Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
DE69225971T 1991-07-01 1992-07-01 Pen-polymorphismus von menschlichem plättchenmembran-glykoprotein-iiia und diagnostische und therapeutische anwendung davon Expired - Lifetime DE69225971D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72132191A 1991-07-01 1991-07-01
PCT/US1992/005391 WO1993001315A1 (en) 1991-07-01 1992-07-01 PEN POLYMORPHISM OF HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIa AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREOF

Publications (1)

Publication Number Publication Date
DE69225971D1 true DE69225971D1 (de) 1998-07-23

Family

ID=24897491

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69225971T Expired - Lifetime DE69225971D1 (de) 1991-07-01 1992-07-01 Pen-polymorphismus von menschlichem plättchenmembran-glykoprotein-iiia und diagnostische und therapeutische anwendung davon

Country Status (7)

Country Link
US (2) US5972601A (de)
EP (1) EP0593572B1 (de)
JP (1) JPH06508993A (de)
AT (1) ATE167525T1 (de)
AU (1) AU2254792A (de)
DE (1) DE69225971D1 (de)
WO (1) WO1993001315A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2254792A (en) * 1991-07-01 1993-02-11 Blood Center Of Southeastern Wisconsin, The Pen polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic application thereof
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
ATE364717T1 (de) * 1996-01-17 2007-07-15 Sequenom Gemini Ltd Diagnose durch bestimmung von polymorphismen in der promoterregion des tgf-beta 1 gens
EP1356298B1 (de) 2000-11-30 2011-05-18 Crawford Healthcare Holdings Limited Krankheitsdiagnose
US6596489B2 (en) 2001-03-30 2003-07-22 Applied Gene Technologies Methods and compositions for analyzing nucleotide sequence mismatches using RNase H
CA2897983A1 (en) 2004-02-06 2005-08-18 Canadian Blood Services A method for the simultaneous determination of blood group and platelet antigen genotypes
US20100285478A1 (en) 2009-03-27 2010-11-11 Life Technologies Corporation Methods, Compositions, and Kits for Detecting Allelic Variants
EP2376659B1 (de) 2008-12-17 2015-12-02 Life Technologies Corporation Verfahren, zusammensetzungen und kits für den nachweis von allelen varianten
CN101445832B (zh) * 2008-12-23 2011-09-14 广州益善生物技术有限公司 Pik3ca基因突变的检测探针、液相芯片及其检测方法
CN101487051B (zh) * 2009-02-24 2011-07-20 广州益善生物技术有限公司 Braf基因突变的检测探针、液相芯片及其检测方法
JP5940771B2 (ja) * 2010-07-12 2016-06-29 アークレイ株式会社 abl遺伝子多型の検出用プローブおよびその用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
CA2000048A1 (en) * 1988-10-03 1990-04-03 Edward F. Plow Peptides and antibodies that inhibit integrin-ligand bindin g
ATE217887T1 (de) * 1988-12-22 2002-06-15 Genentech Inc Verfahren zur herstellung von wasserlöslichen polypeptiden
US5091302A (en) * 1989-04-27 1992-02-25 The Blood Center Of Southeastern Wisconsin, Inc. Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
JPH02300664A (ja) * 1989-05-16 1990-12-12 Olympus Optical Co Ltd 抗血小板抗体検出用試薬
US5436163A (en) * 1989-12-01 1995-07-25 The Blood Center Of Southeastern Wisconsin Polymorphism of human platelet membrane glycoprotein IIb and diagnostic applications thereof
US5177188A (en) * 1990-12-03 1993-01-05 The Scripps Research Institute Methods and compositions for diagnosing chronic immune thrombocytopenic purpura
AU2254792A (en) * 1991-07-01 1993-02-11 Blood Center Of Southeastern Wisconsin, The Pen polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic application thereof

Also Published As

Publication number Publication date
EP0593572B1 (de) 1998-06-17
AU2254792A (en) 1993-02-11
EP0593572A1 (de) 1994-04-27
WO1993001315A1 (en) 1993-01-21
JPH06508993A (ja) 1994-10-13
EP0593572A4 (en) 1994-08-24
US5780229A (en) 1998-07-14
US5972601A (en) 1999-10-26
ATE167525T1 (de) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE161055T1 (de) Polymorphie des glykoproteins iiia der menschlichen blutplättchenmembran und diagnostische applikation davon
DE69225971D1 (de) Pen-polymorphismus von menschlichem plättchenmembran-glykoprotein-iiia und diagnostische und therapeutische anwendung davon
DE69533942D1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
PT939804E (pt) Neutroquina alfa
DE59010941D1 (de) TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
DE69503129T2 (de) Pteridin-nukleotidderivate als fluoreszierende sonden
NO903059L (no) Ligander og reseptorer omfattende nevnte ligander, fremgangsmaate for deres fremstilling og anvendelse.
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
DE3783282T2 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
ATE121793T1 (de) Detektion von pneumocystis carinii durch die verwendung von nukleinsäuresonden.
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
DE3751307D1 (de) Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna-sequenzen in menschlichen zellen enthalten.
DE69329656D1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase-peptidantigenen exprimierenden zellen
DE69022362D1 (de) Nukleinsäuresonden für die detektion von neisseria gonorrhoeae.
DE69033810T2 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
ATE213279T1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
Soltys et al. IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients-implication of novel neurotensin/NTSR1 pathway in neuroprotection
Davrinche et al. Genetic variants of human B component (BF system) and alpha-1-antitrypsin (PI system) in a population from Sardinia
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
SE9403953D0 (sv) Sequence-based diagnosis
BR9814866A (pt) Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica

Legal Events

Date Code Title Description
8332 No legal effect for de